The effect of activated charcoal on adenine-induced chronic renal failure in rats

Food and Chemical Toxicology

Volumn 65, Issue , 2014, Pages 321-328

  Ali, Badreldin H ^a   Alza'abi, Mohamed ^a   Ramkumar, Aishwarya ^a   Al Lawati, Intisar ^a   Waly, Mostafa I ^a   Beegam, Sumaya ^b   Nemmar, Abderrahim ^b   Brand, Susanne ^c   Schupp, Nicole ^c  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Activated charcoal; Adenine; Chronic renal failure; Uremic toxins

Indexed keywords

ACTIVATED CARBON; CATALASE; CREATININE; GLUTATHIONE; INDICAN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PHOSPHATE; SUPEROXIDE DISMUTASE; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENZYME ACTIVITY; FLUID INTAKE; HISTOPATHOLOGY; KIDNEY MASS; KIDNEY STRUCTURE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; UREA BLOOD LEVEL; URINE VOLUME; WEIGHT CHANGE;

ACTIVATED CHARCOAL; ADENINE; CHRONIC RENAL FAILURE; UREMIC TOXINS;

ADENINE; ANIMALS; BODY WEIGHT; CHARCOAL; KIDNEY FAILURE, CHRONIC; MALE; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 84893117489     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.12.038     Document Type: Article

References (50)

1. Al Za'abi M., Ali B., Al Toubi M. HPLC-fluorescence method for measurement of the uremic toxin indoxyl sulfate in plasma. J. Chromatogr. Sci. 2013, 51:40-43.
2. Ali B.H., Abdelrahman A.M., Al-Salam S., Sudhadevi M., AlMahruqi A.S., Al-Husseni I.S., Beegam S., Dhanasekaran S., Nemmar A., Al-Moundhri M. The effect of sildenafil on cisplatin nephrotoxicity in rats. Basic Clin. Pharmacol. Toxicol. 2011, 109:300-308.
3. Ali B.H., Al-Husseni I., Beegam S., Al-Shukaili A., Nemmar A., Schierling S., Queisser N., Schupp N. Effect of gum Arabic on oxidative stress and inflammation in adenine-induced chronic renal failure in rats. PLoS ONE 2013, 8:e55242.
4. Ali B.H., Al-Salam S., Al Husseni I., Kayed R.R., Al-Masroori N., Al-Harthi T., Al Zaabi M., Nemmar A. Effects of Gum Arabic in rats with adenine-induced chronic renal failure. Exp. Biol. Med. (Maywood, NJ) 2010, 235:373-382.
5. Ali B.H., Al-Salam S., Al Za'abi M., Waly M.I., Ramkumar A., Beegam S., Al-Lawati I., Adham S.A., Nemmar A. New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats. J. Pharmacol. Toxicol. Methods 2013, 68:384-393.
6. Aoyama I., Miyazaki T., Niwa T. Preventive effects of an oral sorbent on nephropathy in rats. Miner. Electrolyte Metab. 1999, 25:365-372.
7. Ash S.R. Sorbents in treatment of uremia: a short history and a great future. Semin. Dial. 2009, 22:615-622.
8. Burke S.K. Phosphate is a uremic toxin. J. Ren. Nutr. 2008, 18:27-32.
9. Cooney D.O. Activated Charcoal in Medical Applications 1995, Marcel Dekker, New York.
10. Correia R.T., Borges K.C., Medeiros M.F., Genovese M.I. Bioactive compounds and phenolic-linked functionality of powdered tropical fruit residues. Food Sci. Technol. Int. = Ciencia y tecnologia de los alimentos internacional 2012, 18:539-547.
11. Damment S., Secker R., Shen V., Lorenzo V., Rodriguez M. Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure. Nephrol. Dial. Transplant. 2011, 26:1803-1812.
12. de Vries A., Sperling O. Implications of disorders of purine metabolism for the kidney and the urinary tract. Ciba Found. Symp. 1977, 179-206.
13. Dimmler A., Haas C.S., Cho S., Hattler M., Forster C., Peters H., Schocklmann H.O., Amann K. Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu Snake Venom glomerulonephritis. Diagn. Mol. Pathol. 2003, 12:108-117.
14. Diwan V., Mistry A., Gobe G., Brown L. Adenine-induced chronic kidney and cardiovascular damage in rats. J. Pharmacol. Toxicol. Methods 2013, 10.1016/j.vascn.2013.05.006.
15. Emans M.E., Braam B., Diepenbroek A., van der Putten K., Cramer M.J., Wielders J.P., Swinkels D.W., Doevendans P.A., Gaillard C.A. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment. Kidney Blood Pressure Res. 2012, 36:344-354.
16. Fujii H., Nishijima F., Goto S., Sugano M., Yamato H., Kitazawa R., Kitazawa S., Fukagawa M. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress. Nephrol. Dial. Transplant. 2009, 24:2089-2095.
17. Hosohata K., Ando H., Fujiwara Y., Fujimura A. Vanin-1: a potential biomarker for nephrotoxicant-induced renal injury. Toxicology 2011, 290:82-88.
18. Iida A., Kemmochi Y., Kakimoto K., Tanimoto M., Mimura T., Shinozaki Y., Uemura A., Matsuo A., Matsushita M., Miyamoto K. Ferric citrate hydrate, a new phosphate binder, prevents the complications of secondary hyperparathyroidism and vascular calcification. Am. J. Nephrol. 2013, 37:346-358.
19. Ikeda R., Imai Y., Maruyama W., Mizoguchi K. Systemic disorders of calcium dynamics in rats with adenine-induced renal failure: implication for chronic kidney disease-related complications. Nephrology (Carlton Vic) 2010, 15:54-62.
20. Ito S., Higuchi Y., Yagi Y., Nishijima F., Yamato H., Ishii H., Osaka M., Yoshida M. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. J. Leukoc. Biol. 2013, 93:837-845.
21. Itoh Y., Ezawa A., Kikuchi K., Tsuruta Y., Niwa T. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Anal. Bioanal. Chem. 2012, 403:1841-1850.
22. Jin K. Effects of amino acids and albumin on erythropoietin carbamoylation. Clin. Exp. Nephrol. 2012, 10.1007/s10157-012-0751-y.
23. Kearney T.E. Charcoal, activated. Poisoning & Drug Overdose 1998, 351-353. Appleton & Lange. third ed. K.R. Olson (Ed.).
24. Kinugasa E. Markers and possible uremic toxins: Japanese experiences. Contrib. Nephrol. 2011, 168:134-138.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
26. Miyazaki T., Aoyama I., Ise M., Seo H., Niwa T. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol. Dial. Transplant. 2000, 15:1773-1781.
27. Musso C.G., Michelangelo H., Reynaldi J., Martinez B., Vidal F., Quevedo M., Parot M., Waisman G., Algranati L. Combination of oral activated charcoal plus low protein diet as a new alternative for handling in the old end-stage renal disease patients. Saudi J. Kidney Dis. Transpl. 2010, 21:102-104.
28. Niwa T. Indoxyl sulfate is a nephro-vascular toxin. J. Ren. Nutr. 2010, 20. S2-S6.
29. Okabe C., Borges R.L., de Almeida D.C., Fanelli C., Barlette G.P., Machado F.G., Arias S.C., Malheiros D.M., Camara N.O., Zatz R., Fujihara C.K. NF-kappaB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy. Am. J. Physiol. Renal. Physiol. 2013, 305. F155-F163.
30. Olson K.R. Activated charcoal for acute poisoning: one toxicologist's journey. J. Med. Toxicol. 2010, 6:190-198.
31. Orisakwe O.E., Ilondu N.A., Afonne O.J., Ofoefule S.I., Orish C.N. Acceleration of body clearance of diethylCarbamazine by oral activated charcoal. Pharmacol. Res. 2000, 42:167-170.
32. Osterhoudt K.C., Alpern E.R., Durbin D., Nadel F., Henretig F.M. Activated charcoal administration in a pediatric emergency department. Pediatr. Emerg. Care 2004, 20:493-498.
33. Perez-Severiano F., Salvatierra-Sanchez R., Rodriguez-Perez M., Cuevas-Martinez E.Y., Guevara J., Limon D., Maldonado P.D., Medina-Campos O.N., Pedraza-Chaverri J., Santamaria A. S-Allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. Eur. J. Pharmacol. 2004, 489:197-202.
34. Raij L., Azar S., Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984, 26:137-143.
35. Sarithakumari C.H., Renju G.L., Kurup G.M. Anti-inflammatory and antioxidant potential of alginic acid isolated from the marine algae, Sargassum wightii on adjuvant-induced arthritic rats. Inflammopharmacology 2013, 21:261-268.
36. Schulman G. A nexus of progression of chronic kidney disease: tryptophan, profibrotic cytokines, and charcoal. J. Ren. Nutr. 2012, 22:107-113.
37. Schulman G., Agarwal R., Acharya M., Berl T., Blumenthal S., Kopyt N. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am. J. Kidney Dis. 2006, 47:565-577.
38. Seck S.M., Gueye S., Tamba K., Ba I. Prevalence of chronic cardiovascular and metabolic diseases in Senegalese workers: a cross-sectional study, 2010. Prevent. Chronic Dis. 2013, 10:110339.
39. Shen B., Pardi D.S., Bennett A.E., Queener E., Kammer P., Hammel J.P., LaPlaca C., Harris M.S. The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis. Am. J. Gastroenterol. 2009, 104:1468-1474.
40. Stockelman M.G., Lorenz J.N., Smith F.N., Boivin G.P., Sahota A., Tischfield J.A., Stambrook P.J. Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Am. J. Physiol. 1998, 275. F154-F163.
41. Vaziri N.D., Yuan J., Khazaeli M., Masuda Y., Ichii H., Liu S. Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption. Am. J. Nephrol. 2013, 37:518-525.
42. Wang J., Wang F., Yun H., Zhang H., Zhang Q. Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease. J. Ethnopharmacol. 2012, 139:807-813.
43. Waring W.S., Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clin. Toxicol. (Philadelphia Pa) 2011, 49:720-728.
44. Winchester J.F., Ronco C. Sorbent augmented hemodialysis systems: are we there yet?. J. Am. Soc. Nephrol. 2010, 21:209-211.
45. Wyngaarden J.B., Dunn J.T. 8-Hydroxyadenine as the intermediate in the oxidation of adenine to 2, 8-dihydroxyadenine by xanthine oxidase. Arch. Biochem. Biophys. 1957, 70:150-156.
46. Yamamoto S., Zuo Y., Ma J., Yancey P.G., Hunley T.E., Motojima M., Fogo A.B., Linton M.F., Fazio S., Ichikawa I., Kon V. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrol. Dial. Transplant. 2011, 26:2491-2497.
47. Yavuz A., Tetta C., Ersoy F.F., D'Intini V., Ratanarat R., De Cal M., Bonello M., Bordoni V., Salvatori G., Andrikos E., Yakupoglu G., Levin N.W., Ronco C. Uremic toxins: a new focus on an old subject. Semin. Dial. 2005, 18:203-211.
48. Yokozawa T., Zheng P.D., Oura H., Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron 1986, 44:230-234.
49. Zhao Y.Y., Cheng X.L., Cui J.H., Yan X.R., Wei F., Bai X., Lin R.C. Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. Clin. Chim. Acta; Int. J. Clin. Chem. 2012, 413:1438-1445.
50. Zhao Y.Y., Cheng X.L., Wei F., Bai X., Tan X.J., Lin R.C., Mei Q. Intrarenal metabolomic investigation of chronic kidney disease and its TGF-beta1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E). J. Proteome Res. 2013, 12:692-703.